Treatment with these agents was also found to have no significant effect on downregulated PPARγ levels in PPARγ siRNA transfected MCF-7 (Figure 8(a)) and MDA-MB-231 (Figure 8(b)) breast cancer cells. Here, PPARG is linked to breast cancer.